Inventor · disambiguated record
Yu Xia
Also filed as: XIA YU · XIA YU PEGGY
28 granted patents·40 pending applications·101 citations·filing 2005–2024
94Inventor score
Files withAKESO BIOPHARMA INC32AKESO PHARMACEUTICALS INC5VIMICRO CORP BEIJING4CTTQ AKESO SHANGHAI BIOMED TECH CO LTD3SUZHOU JUFENG ELECTRICAL INSULATION SYSTEM CO LTD3
Top patents by PatentIndex Score
68 records- 0194US12195527B2Anti-PD-1/VEGFA bifunctional antibody, pharmaceutical composition thereofAKESO BIOPHARMA INC·Filed 2023·Granted Jan 14, 2025·2 cites·24 claims
- 0293US7328848B2Method and system for transmitting data based on two-dimensional symbol technologiesVIMICRO CORP BEIJING·Filed 2005·Granted Feb 12, 2008·48 cites·10 claims
- 0391US11578128B2Anti-CTLA4 and anti-PD-1 bifunctional antibody, pharmaceutical composition thereof and use thereofAKESO PHARMACEUTICALS INC·Filed 2017·Granted Feb 14, 2023·7 cites·29 claims
- 0491US10449251B2Anti-CTLA4 monoclonal antibody or its antigen binding fragments, pharmaceutical compositions and usesAKESO BIOPHARMA INC·Filed 2015·Granted Oct 22, 2019·6 cites·20 claims
- 0584US7853050B2System and method for operation without touch by operatorsVIMICRO CORP BEIJING·Filed 2006·Granted Dec 14, 2010·24 cites·14 claims
- 0683US12076398B2Anti-PD1 monoclonal antibody, pharmaceutical composition thereof and use thereofCTTQ AKESO SHANGHAI BIOMED TECH CO LTD·Filed 2017·Granted Sep 3, 2024·3 cites·6 claims
- 0781US2025223346A1Monoclonal antibody against nerve growth factor, and encoding gene and use thereofAKESO BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 0881US2025197487A1Anti-pd-1/vegfa bifunctional antibody, pharmaceutical composition thereof and use thereofAKESO BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 0980US11136413B2PDL-1 antibody, pharmaceutical composition thereof, and uses thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2019·Granted Oct 5, 2021·1 cites·40 claims
- 1079US10670604B2PCSK9 antibody, and pharmaceutical composition and use thereofAD PHARMACEUTICAL CO INC·Filed 2016·Granted Jun 2, 2020·2 cites·12 claims
- 1178US11402383B2Nucleic acid encoding PCSK9 antibodyAD PHARMACEUTICAL CO INC·Filed 2020·Granted Aug 2, 2022·1 cites·19 claims
- 1278US10465014B2PDL-1 antibody, pharmaceutical composition thereof, and uses thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2017·Granted Nov 5, 2019·1 cites·64 claims
- 1377US12447208B2Anti-CTLA4 monoclonal antibody or its antigen binding fragments, pharmaceutical compositions and usesAKESO BIOPHARMA INC·Filed 2022·Granted Oct 21, 2025·0 cites·14 claims
- 1477US11479608B2Anti-CTLA4 antibodiesAKESO BIOPHARMA INC·Filed 2017·Granted Oct 25, 2022·1 cites·24 claims
- 1575US2024025983A1Monoclonal antibody against nerve growth factor, and encoding gene and use thereofAKESO BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 1675US2025041409A1Anti-pd1 monoclonal antibody, pharmaceutical composition thereof and use thereofCTTQ AKESO SHANGHAI BIOMED TECH CO LTD·Filed 2024·Application pending·0 cites
- 1773US12479919B2Anti-CTLA4 and anti-PD-1 bifunctional antibody, pharmaceutical composition thereof and use thereofAKESO PHARMACEUTICALS INC·Filed 2022·Granted Nov 25, 2025·0 cites·22 claims
- 1873US12390458B2Therapeutic combination of quinoline derivative and antibodyCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2019·Granted Aug 19, 2025·1 cites·14 claims
- 1972US2025368735A1Bispecific antibody containing anti-cldn18.2 antibody, and pharmaceutical composition and use thereofAKESO BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 2072US2025376517A1Anti-cldn18.2 antibody, and pharmaceutical composition and use thereofAKESO BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 2170US11291720B2Anti-CTLA4 monoclonal antibody or its antigen binding fragments, pharmaceutical compositions and usesAKESO BIOPHARMA INC·Filed 2019·Granted Apr 5, 2022·0 cites·35 claims
- 2269US2024392040A1Anti-lag3 bispecific antibody, pharmaceutical composition and useAKESO HUIKE SHANGHAI CO LTD·Filed 2022·Application pending·0 cites
- 2369US2025042995A1Anti-lag3 antibody, pharmaceutical composition and useAKESO BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 2468US2021340239A1Anti-pd-1/vegfa bifunctional antibody, pharmaceutical composition thereof and use thereofAKESO BIOPHARMA INC·Filed 2019·Application pending·0 cites
- 2565US2025011555A1High-strength flame-retardant mxene/phosphorylated cellulose fibril composite film and preparation method thereofSUZHOU JUFENG ELECTRICAL INSULATION SYSTEM CO LTD·Filed 2023·Application pending·0 cites
- 2664US12286473B2Anti-IL-1β antibody and pharmaceutical composition thereof and use of sameAKESO BIOPHARMA INC·Filed 2019·Granted Apr 29, 2025·0 cites·21 claims
- 2764US8326583B2CAD system and method for blend recognition and chain sorting in a Brep modelYU FENG·Filed 2009·Granted Dec 4, 2012·4 cites·20 claims
- 2864US2025304703A1Anti-human il-4ra antibody and application thereofAKESO BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 2963US11680095B2Monoclonal antibody against nerve growth factor, and encoding gene and use thereofAKESO BIOPHARMA INC·Filed 2019·Granted Jun 20, 2023·0 cites·21 claims
- 3063US2024117051A1Therapeutic combination and use thereofAKESO BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 3163US2025129163A1Pharmaceutical composition and use thereofAKESO BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 3263US2025034253A1Pharmaceutical composition comprising anti-tigit antibody and anti-pd-1/anti-vegfa bispecific antibody, and use thereofAKESO BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 3362US12476960B2End-to-end context isolation across microservices in a multi-tenant distributed cloud infrastructureMICROSOFT TECHNOLOGY LICENSING LLC·Filed 2023·Granted Nov 18, 2025·0 cites·20 claims
- 3462US2025188164A1Pharmaceutical composition comprising anti-ctla4-anti-pd-1 bispecific antibody and chiauranibAKESO PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 3561US11837384B2Corona-resistant enameled round wire and preparation method thereforSHANGHAI XPT TECH LTD·Filed 2022·Granted Dec 5, 2023·0 cites·18 claims
- 3661US2025319169A2FUSION PROTEIN CONTAINING ANTI-TIGIT ANTIBODY AND TGF-ßR, AND PHARMACEUTICAL COMPOSITION AND USE THEREOFAKESO BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 3760US2024352153A1Pharmaceutical composition and useAKESO BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 3858US2025114450A1Pharmaceutical combination containing anti-pd-1-anti-vegfa bispecific antibody, and use thereofAKESO BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 3958US2024043531A1Anti-cd47 monoclonal antibody and use thereofAKESO BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 4057US2024002504A1Anti-tigit antibody, and pharmaceutical composition and use thereofAKESO BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 4157US2024018254A1Anti-cd73 antibody and use thereofAKESO BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 4256US2024218074A1Anti-cd73 antibody and use thereofAKESO BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 4355US2022340639A1Allogeneic car-t cell, preparation therefor, and application thereofFUNDAMENTA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4454US2024199741A1Use of antibody in anti-tumor treatmentAKESO PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 4554US2023159655A1Anti-cd73 antibody and use thereofAKESO BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 4654US2023151111A1Anti-cd73-anti-pd-1 bispecific antibody and use thereofAKESO BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 4753US2023312750A1Anti-pcsk9 antibody and use thereofAD PHARMACEUTICALS CO LTD·Filed 2020·Application pending·0 cites
- 4853US2022313736A1Allogeneic car-t cell, preparation therefor, and application thereofFUNDAMENTA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4953US2023355742A1Fusion gene, recombinant novel coronavirus high-efficiency immune dna vaccine, construction method and use thereofAURORA GENEVAC BIOTECH CO LTD·Filed 2021·Application pending·0 cites
- 5052US2023027029A1Anti-pd-1-anti-vegfa bispecific antibody, pharmaceutical composition and use thereofAKESO BIOPHARMA INC·Filed 2020·Application pending·0 cites
Showing the top 50 of 68 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Yu Xia files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →